Predicted protein targets (top 3)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ENPEP | Q07075 | 1/20 | 0.36 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.30 |
| ▸ | TSHR | P16473 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL571022 | 0.83 | CHRM2 (0.35) | — | |
| SCHEMBL15436603 | 0.82 | TDP1 (0.40) | TSHR | |
| SCHEMBL8496802 | 0.79 | DNM1 (0.33) | ENPEP | |
| SCHEMBL8493869 | 0.79 | ENPEP (0.32) | ENPEP | |
| SCHEMBL4851820 | 0.77 | OPRM1 (0.41) | TSHR | |
| SCHEMBL8490453 | 0.76 | ENPEP (0.33) | ENPEP | |
| SCHEMBL2264972 | 0.76 | CYP2C9 (0.36) | — | |
| SCHEMBL16163286 | 0.76 | DNM1 (0.44) | TSHR | |
| SCHEMBL16163245 | 0.76 | DNM1 (0.44) | TSHR | |
| SCHEMBL16163299 | 0.76 | DNM1 (0.44) | TSHR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20070010004-A1 | Micellar systems | ROCHE MADISON INC. | 2007-01-11 | — | — | US | disclosed |
| US-7091041-B2 | Micellar systems | MIRUS BIO CORPORATION (US) | 2006-08-15 | — | — | US | disclosed |
| US-20040023393-A1 | Micellar systems | ROCHE MADISON INC. | 2004-02-05 | — | — | US | disclosed |
| US-6673612-B2 | GENERATION OF MICELLE FOR THE TRANSFER OF BIOPOLYMERS TO CELLS; FORM CATIONIC REVERSE MICELLE USING AMPHIPATHIC MOLECULES, INSERT BIPOLYMER, ADJUST THE CHARGE OF MICELLE , TRANSFER TO CELLS | MIRUS CORPORATION | 2004-01-06 | — | — | US | disclosed |
| US-20030027339-A1 | Micellar systems | ROCHE MADISON INC. | 2003-02-06 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070010004-A1 | Micellar systems | POLRMT, NSUN3, NSUN2 | ENPEP 3189/4885CYP3A4 4751/4885TSHR 1419/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.